5-Amino-1MQ (5Amino-1MQ) is an experimental small molecule studied for its effects on fat metabolism and cellular energy regulation. It is not FDA-approved and is considered a research compound.
Here’s what it appears to do in the body:
⸻
1. Inhibits NNMT (Nicotinamide N-methyltransferase)
5-Amino-1MQ primarily works by inhibiting the enzyme NNMT.
NNMT plays a role in:
•Fat cell metabolism
•NAD⁺ regulation
•Energy balance
Higher NNMT activity is associated with:
•Obesity
•Insulin resistance
•Slower metabolism
By inhibiting NNMT, 5-Amino-1MQ may shift cells toward a more metabolically active state.
⸻
2. Increases Cellular NAD⁺ Availability (Indirectly)
When NNMT activity is reduced:
•NAD⁺ levels may increase
•Mitochondrial function may improve
•Energy production efficiency may rise
NAD⁺ is central to metabolic health and aging pathways.
⸻
3. Fat Loss Effects (Animal Data)
In rodent studies, NNMT inhibition led to:
•Reduced fat mass
•Increased lipolysis (fat breakdown)
•Higher energy expenditure
•Improved insulin sensitivity
Importantly, some weight reduction occurred without appetite suppression, unlike drugs such as Tirzepatide.
However:
•Human clinical trials are extremely limited
•Long-term safety is unknown
⸻
4. Possible Metabolic Reprogramming
Because NNMT influences epigenetics and methylation pathways, 5-Amino-1MQ may:
•Alter gene expression related to metabolism
•Improve metabolic flexibility
•Reduce fat storage signaling
But this area is still under active research.
⸻
5. Potential Body Composition Effects
Based on preclinical data, it may:
•Reduce visceral fat
•Preserve lean mass
•Improve glucose tolerance
Again, mostly animal data.
In Simple Terms
5-Amino-1MQ may:
•Increase metabolic rate at the cellular level
•Improve insulin sensitivity
•Reduce fat accumulation
•Enhance NAD⁺ availability
It’s more of a cellular metabolism modifier than a hormone or appetite-based fat loss compound.